ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 270737 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 270737; 2) Community: the network communities that were significantly associated with the response to NSC 270737; 3) Molecule: the relationships between components within communities and NSC 270737; 4) MDR: the compounds that were significantly associated with the NSC 270737.

NSC Compound Enrichment Correlation
NSC 746691 (2E)-2-Benzoyl-3-(2-phenyl-1H-indol-3-yl)acrylonitrile 0.0422061523786546 0.20513944
NSC 756469 SB-732881 0.0422061523786546 0.1899868
NSC 759263 Topotecan hydrochloride (USAN) 0.0422061523786546 0.18288258
NSC 761814 3-(4-(5-methoxy-1H-benzo[d]imidazol-2-yl)phenyl)-5-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazole 0.0422061523786546 0.35412701
NSC 77495 9H-Purine-6-thiol, 9-.beta.-D-ribofuranosyl-, 2',3',5'-trivalerate, hemihydrate 0.0422061523786546 0.22634894
NSC 91745 9H-Purine, 6-[(1-methyl-4-nitroimidazol-5-yl)thio]-9-.beta.-D-ribofuranosyl-, compd. with ethyl alcohol (4:1) 0.0422061523786546 0.22356399
NSC 109555 DDUG 0.0422061523786552 0.35701737
NSC 19441 FDA 0283 0.0422061523786552 0.1035957
Total:23  Current:23    [First] [Prev] [Next] [Last]